These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 4621798)

  • 1. Comparison of fluorescent antibody induced by rubella virus in vaccinee and convalescent individuals.
    Serafini A; Cole GC; Brackett RG
    Appl Microbiol; 1972 Jan; 23(1):66-71. PubMed ID: 4621798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rubella precipitin response in natural infection and in vaccination.
    Paul NR; Rhodes AJ; Campbell JB; Labzoffsky NA
    Arch Gesamte Virusforsch; 1974; 45(4):335-51. PubMed ID: 4216341
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunization with live attenuated rubella virus vaccine (HPV-77). Clinical and serological results in children and adolescents in Israel.
    Goldblum N; Swartz TA; Klingberg W; Goldwasser RA; Klingberg MA
    Am J Dis Child; 1969 Aug; 118(2):190-6. PubMed ID: 5815861
    [No Abstract]   [Full Text] [Related]  

  • 4. Antibody response to rubella virion (V) and soluble (S) antigens in rubella infection and following vaccination with live attenuated rubella virus.
    Vesikari T; Vaheri A; Leinikki P
    Arch Gesamte Virusforsch; 1971; 35(1):25-37. PubMed ID: 4943281
    [No Abstract]   [Full Text] [Related]  

  • 5. Production of rubella virus vaccine. Live, attenuated in canine renal cell cultures.
    Musser SJ; Hilsabeck LJ
    Am J Dis Child; 1969 Aug; 118(2):355-61. PubMed ID: 4978513
    [No Abstract]   [Full Text] [Related]  

  • 6. Measurement of rubella antibody by hemagglutination inhibition. I. Variables affecting rubella hemagglutination.
    Liebhaber H
    J Immunol; 1970 Apr; 104(4):818-25. PubMed ID: 5462589
    [No Abstract]   [Full Text] [Related]  

  • 7. The application of different cell lines and virus strains for detection of immunofluorescence rubella antibodies.
    Jankowski M; Gut W; Imbs D; Kańtoch M
    Acta Microbiol Pol; 1977; 26(4):439-46. PubMed ID: 75674
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Some biological and immunizing properties of a high-titered freeze-dried EDTA-released rubella virus hemagglutinin containing live virus.
    Straus J
    Arch Gesamte Virusforsch; 1971; 34(2):96-104. PubMed ID: 5005508
    [No Abstract]   [Full Text] [Related]  

  • 9. Modified hemagglutination-inhibition test for rubella employing human group O erythrocytes.
    Schmidt NJ; Dennis J
    Appl Microbiol; 1972 Mar; 23(3):471-5. PubMed ID: 5063201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutralizing and hemagglutination-inhibiting antibodies to rubella virus as indicators of protective immunity in vaccinees and naturally immune individuals.
    Schluederberg A; Horstmann DM; Andiman WA; Randolph MF
    J Infect Dis; 1978 Dec; 138(6):877-83. PubMed ID: 105058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review of studies with inactivated rubella virus.
    Beck ES
    Am J Dis Child; 1969 Aug; 118(2):328-33. PubMed ID: 4979428
    [No Abstract]   [Full Text] [Related]  

  • 12. Loss of rubella hemagglutination inhibition antibody in congenital rubella. Failure of seronegative children with congenital rubella to respond to HPV-77 rubella vaccine.
    Cooper LZ; Florman AL; Ziring PR; Krugman S
    Am J Dis Child; 1971 Nov; 122(5):397-403. PubMed ID: 5129528
    [No Abstract]   [Full Text] [Related]  

  • 13. Diagnosis of rubella virus infections. I. A comparison between Vero and BHK-21 cells for the detection of specific IgG and IgM antibodies by immunofluorescence.
    Payment P; Roy L; Gilker JC; Chagnon A
    Can J Microbiol; 1975 Mar; 21(3):289-92. PubMed ID: 803860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of proflavine on rubella virus replication in baby hamster kidney (BHK-21) cells.
    Booth JC; Stern H
    Arch Gesamte Virusforsch; 1972; 37(2):253-61. PubMed ID: 4623867
    [No Abstract]   [Full Text] [Related]  

  • 15. Live attenuated rubella virus vaccines in young adult women. Trials of Cendehill and HPV-77 DE-5.
    Byrne EB; Ryan JM; Randolph MF; Horstmann DM
    Am J Dis Child; 1969 Aug; 118(2):234-6. PubMed ID: 4183351
    [No Abstract]   [Full Text] [Related]  

  • 16. Large-scale purification of rubella virus and preparation of an experimental split rubella virus vaccine.
    Väänänen P; Vaheri A
    Appl Microbiol; 1971 Sep; 22(3):255-9. PubMed ID: 5119198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials of RA 27-3 (Wistar) rubella vaccine in Japan.
    Furukawa T; Miyata T; Kondo K; Kuno K; Isomura S; Takekoshi T
    Am J Dis Child; 1969 Aug; 118(2):262-3. PubMed ID: 4978510
    [No Abstract]   [Full Text] [Related]  

  • 18. Live attenuated rubella virus vaccines. Experiences with duck embryo cell preparations.
    Hilleman MR; Buynak EB; Whitman JE; Weibel RW; Stokes J
    Am J Dis Child; 1969 Aug; 118(2):166-71. PubMed ID: 5815860
    [No Abstract]   [Full Text] [Related]  

  • 19. Attenuated rubella vaccination in families: observations on the lack of fluorescent antibody response and on the use of blood collected on filter paper discs in the hemagglutination-inhibition test.
    Monto AS; Cavallaro JJ; Brown GC
    J Lab Clin Med; 1969 Jul; 74(1):98-102. PubMed ID: 4892624
    [No Abstract]   [Full Text] [Related]  

  • 20. Artificial challenge studies in rubella. Utilization of RA 27-3 rubella vaccines, rubella naturally acquired seropositives, and rubella susceptible children.
    Naficy K; Nategh R; Ahangary S; Mohsenin H
    Am J Dis Child; 1970 Dec; 120(6):520-3. PubMed ID: 5481902
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.